Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluMist Shedding, Immunogenicity, and Safety in Healthy Individuals
NCT00192140Phase 4Completed
- Sponsor
- MedImmune
- Start
- Jun 2004
- Primary completion
- Oct 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by MedImmune. Started Jun 2004; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192140.